S&P 500   3,844.84 (+0.08%)
DOW   31,928.64 (+1.37%)
QQQ   304.04 (-1.50%)
AAPL   117.72 (-3.05%)
MSFT   230.06 (-0.66%)
FB   259.18 (-1.93%)
GOOGL   2,041.00 (-2.67%)
TSLA   577.63 (-3.40%)
AMZN   3,002.00 (+0.05%)
NVDA   472.42 (-5.22%)
BABA   228.27 (-2.40%)
CGC   31.41 (+0.77%)
GE   14.20 (+4.41%)
MU   86.62 (-2.60%)
NIO   36.15 (-5.14%)
AMD   75.61 (-3.71%)
T   30.33 (+2.40%)
F   12.68 (+3.34%)
ACB   9.73 (+1.35%)
DIS   200.46 (+5.51%)
BA   227.18 (+1.77%)
NFLX   502.94 (-2.60%)
PFE   34.66 (+0.79%)
S&P 500   3,844.84 (+0.08%)
DOW   31,928.64 (+1.37%)
QQQ   304.04 (-1.50%)
AAPL   117.72 (-3.05%)
MSFT   230.06 (-0.66%)
FB   259.18 (-1.93%)
GOOGL   2,041.00 (-2.67%)
TSLA   577.63 (-3.40%)
AMZN   3,002.00 (+0.05%)
NVDA   472.42 (-5.22%)
BABA   228.27 (-2.40%)
CGC   31.41 (+0.77%)
GE   14.20 (+4.41%)
MU   86.62 (-2.60%)
NIO   36.15 (-5.14%)
AMD   75.61 (-3.71%)
T   30.33 (+2.40%)
F   12.68 (+3.34%)
ACB   9.73 (+1.35%)
DIS   200.46 (+5.51%)
BA   227.18 (+1.77%)
NFLX   502.94 (-2.60%)
PFE   34.66 (+0.79%)
S&P 500   3,844.84 (+0.08%)
DOW   31,928.64 (+1.37%)
QQQ   304.04 (-1.50%)
AAPL   117.72 (-3.05%)
MSFT   230.06 (-0.66%)
FB   259.18 (-1.93%)
GOOGL   2,041.00 (-2.67%)
TSLA   577.63 (-3.40%)
AMZN   3,002.00 (+0.05%)
NVDA   472.42 (-5.22%)
BABA   228.27 (-2.40%)
CGC   31.41 (+0.77%)
GE   14.20 (+4.41%)
MU   86.62 (-2.60%)
NIO   36.15 (-5.14%)
AMD   75.61 (-3.71%)
T   30.33 (+2.40%)
F   12.68 (+3.34%)
ACB   9.73 (+1.35%)
DIS   200.46 (+5.51%)
BA   227.18 (+1.77%)
NFLX   502.94 (-2.60%)
PFE   34.66 (+0.79%)
S&P 500   3,844.84 (+0.08%)
DOW   31,928.64 (+1.37%)
QQQ   304.04 (-1.50%)
AAPL   117.72 (-3.05%)
MSFT   230.06 (-0.66%)
FB   259.18 (-1.93%)
GOOGL   2,041.00 (-2.67%)
TSLA   577.63 (-3.40%)
AMZN   3,002.00 (+0.05%)
NVDA   472.42 (-5.22%)
BABA   228.27 (-2.40%)
CGC   31.41 (+0.77%)
GE   14.20 (+4.41%)
MU   86.62 (-2.60%)
NIO   36.15 (-5.14%)
AMD   75.61 (-3.71%)
T   30.33 (+2.40%)
F   12.68 (+3.34%)
ACB   9.73 (+1.35%)
DIS   200.46 (+5.51%)
BA   227.18 (+1.77%)
NFLX   502.94 (-2.60%)
PFE   34.66 (+0.79%)
Log in
NYSE:MTD

Mettler-Toledo International Competitors

$1,051.83
-8.76 (-0.83 %)
(As of 03/8/2021 02:39 PM ET)
Add
Compare
Today's Range
$1,045.40
Now: $1,051.83
$1,069.84
50-Day Range
$1,059.42
MA: $1,182.69
$1,268.80
52-Week Range
$579.40
Now: $1,051.83
$1,271.67
Volume2,186 shs
Average Volume128,442 shs
Market Capitalization$24.62 billion
P/E Ratio44.25
Dividend YieldN/A
Beta1.04

Competitors

Mettler-Toledo International (NYSE:MTD) Vs. TMO, ILMN, A, BIO, WAT, and PKI

Should you be buying MTD stock or one of its competitors? Companies in the sub-industry of "life sciences tools & services" are considered alternatives and competitors to Mettler-Toledo International, including Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Bio-Rad Laboratories (BIO), Waters (WAT), and PerkinElmer (PKI).

Mettler-Toledo International (NYSE:MTD) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Analyst Recommendations

This is a breakdown of current recommendations for Mettler-Toledo International and Thermo Fisher Scientific, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Mettler-Toledo International47101.75
Thermo Fisher Scientific041602.80

Mettler-Toledo International presently has a consensus price target of $868.0833, indicating a potential downside of 17.56%. Thermo Fisher Scientific has a consensus price target of $529.4211, indicating a potential upside of 17.82%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Thermo Fisher Scientific is more favorable than Mettler-Toledo International.

Insider & Institutional Ownership

93.2% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 87.2% of Thermo Fisher Scientific shares are held by institutional investors. 3.2% of Mettler-Toledo International shares are held by insiders. Comparatively, 0.4% of Thermo Fisher Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Mettler-Toledo International and Thermo Fisher Scientific's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Mettler-Toledo International19.36%144.89%21.11%
Thermo Fisher Scientific17.12%21.35%10.55%

Risk & Volatility

Mettler-Toledo International has a beta of 1.04, indicating that its stock price is 4% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500.

Earnings & Valuation

This table compares Mettler-Toledo International and Thermo Fisher Scientific's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mettler-Toledo International$3.01 billion8.17$561.11 million$22.7746.14
Thermo Fisher Scientific$25.54 billion6.93$3.70 billion$12.3536.41

Thermo Fisher Scientific has higher revenue and earnings than Mettler-Toledo International. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Summary

Mettler-Toledo International beats Thermo Fisher Scientific on 9 of the 14 factors compared between the two stocks.

Mettler-Toledo International (NYSE:MTD) and Illumina (NASDAQ:ILMN) are both large-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Analyst Recommendations

This is a breakdown of current recommendations for Mettler-Toledo International and Illumina, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Mettler-Toledo International47101.75
Illumina48602.11

Mettler-Toledo International presently has a consensus price target of $868.0833, indicating a potential downside of 17.56%. Illumina has a consensus price target of $364.00, indicating a potential downside of 6.66%. Given Illumina's stronger consensus rating and higher probable upside, analysts plainly believe Illumina is more favorable than Mettler-Toledo International.

Insider & Institutional Ownership

93.2% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 90.0% of Illumina shares are held by institutional investors. 3.2% of Mettler-Toledo International shares are held by insiders. Comparatively, 0.4% of Illumina shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Mettler-Toledo International and Illumina's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Mettler-Toledo International19.36%144.89%21.11%
Illumina19.70%15.93%10.09%

Risk & Volatility

Mettler-Toledo International has a beta of 1.04, indicating that its stock price is 4% more volatile than the S&P 500. Comparatively, Illumina has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500.

Earnings & Valuation

This table compares Mettler-Toledo International and Illumina's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mettler-Toledo International$3.01 billion8.17$561.11 million$22.7746.14
Illumina$3.54 billion16.17$1.00 billion$6.5759.75

Illumina has higher revenue and earnings than Mettler-Toledo International. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Summary

Illumina beats Mettler-Toledo International on 9 of the 14 factors compared between the two stocks.

Mettler-Toledo International (NYSE:MTD) and Agilent Technologies (NYSE:A) are both large-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Analyst Recommendations

This is a breakdown of current recommendations for Mettler-Toledo International and Agilent Technologies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Mettler-Toledo International47101.75
Agilent Technologies0101602.62

Mettler-Toledo International presently has a consensus price target of $868.0833, indicating a potential downside of 17.56%. Agilent Technologies has a consensus price target of $100.4619, indicating a potential downside of 14.16%. Given Agilent Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Agilent Technologies is more favorable than Mettler-Toledo International.

Profitability

This table compares Mettler-Toledo International and Agilent Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Mettler-Toledo International19.36%144.89%21.11%
Agilent Technologies13.47%21.02%10.73%

Earnings & Valuation

This table compares Mettler-Toledo International and Agilent Technologies' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mettler-Toledo International$3.01 billion8.17$561.11 million$22.7746.14
Agilent Technologies$5.34 billion6.69$719 million$3.2835.76

Agilent Technologies has higher revenue and earnings than Mettler-Toledo International. Agilent Technologies is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

93.2% of Mettler-Toledo International shares are held by institutional investors. 3.2% of Mettler-Toledo International shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Risk & Volatility

Mettler-Toledo International has a beta of 1.04, indicating that its stock price is 4% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.04, indicating that its stock price is 4% more volatile than the S&P 500.

Summary

Mettler-Toledo International beats Agilent Technologies on 7 of the 13 factors compared between the two stocks.

Bio-Rad Laboratories (NYSE:BIO) and Mettler-Toledo International (NYSE:MTD) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, institutional ownership and earnings.

Analyst Ratings

This is a summary of recent recommendations and price targets for Bio-Rad Laboratories and Mettler-Toledo International, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bio-Rad Laboratories00403.00
Mettler-Toledo International47101.75

Bio-Rad Laboratories presently has a consensus target price of $646.00, suggesting a potential upside of 14.85%. Mettler-Toledo International has a consensus target price of $868.0833, suggesting a potential downside of 17.56%. Given Bio-Rad Laboratories' stronger consensus rating and higher probable upside, equities research analysts plainly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.

Profitability

This table compares Bio-Rad Laboratories and Mettler-Toledo International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bio-Rad Laboratories147.91%3.77%2.74%
Mettler-Toledo International19.36%144.89%21.11%

Valuation and Earnings

This table compares Bio-Rad Laboratories and Mettler-Toledo International's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Rad Laboratories$2.31 billion7.26$1.76 billion$7.0679.67
Mettler-Toledo International$3.01 billion8.17$561.11 million$22.7746.14

Bio-Rad Laboratories has higher earnings, but lower revenue than Mettler-Toledo International. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

63.0% of Bio-Rad Laboratories shares are held by institutional investors. Comparatively, 93.2% of Mettler-Toledo International shares are held by institutional investors. 27.5% of Bio-Rad Laboratories shares are held by company insiders. Comparatively, 3.2% of Mettler-Toledo International shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Risk and Volatility

Bio-Rad Laboratories has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500.

Summary

Mettler-Toledo International beats Bio-Rad Laboratories on 8 of the 14 factors compared between the two stocks.

Waters (NYSE:WAT) and Mettler-Toledo International (NYSE:MTD) are both large-cap computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, institutional ownership and earnings.

Insider & Institutional Ownership

91.8% of Waters shares are held by institutional investors. Comparatively, 93.2% of Mettler-Toledo International shares are held by institutional investors. 1.5% of Waters shares are held by company insiders. Comparatively, 3.2% of Mettler-Toledo International shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of recent recommendations and price targets for Waters and Mettler-Toledo International, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Waters58101.71
Mettler-Toledo International47101.75

Waters presently has a consensus target price of $219.4545, suggesting a potential downside of 18.03%. Mettler-Toledo International has a consensus target price of $868.0833, suggesting a potential downside of 17.56%. Given Mettler-Toledo International's stronger consensus rating and higher probable upside, analysts plainly believe Mettler-Toledo International is more favorable than Waters.

Profitability

This table compares Waters and Mettler-Toledo International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Waters22.61%-349.31%21.11%
Mettler-Toledo International19.36%144.89%21.11%

Valuation and Earnings

This table compares Waters and Mettler-Toledo International's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Waters$2.41 billion6.92$592.20 million$8.9929.78
Mettler-Toledo International$3.01 billion8.17$561.11 million$22.7746.14

Waters has higher earnings, but lower revenue than Mettler-Toledo International. Waters is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Waters has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500.

Summary

Mettler-Toledo International beats Waters on 10 of the 12 factors compared between the two stocks.

PerkinElmer (NYSE:PKI) and Mettler-Toledo International (NYSE:MTD) are both large-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.

Insider and Institutional Ownership

89.4% of PerkinElmer shares are owned by institutional investors. Comparatively, 93.2% of Mettler-Toledo International shares are owned by institutional investors. 0.6% of PerkinElmer shares are owned by company insiders. Comparatively, 3.2% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for PerkinElmer and Mettler-Toledo International, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
PerkinElmer05702.58
Mettler-Toledo International47101.75

PerkinElmer currently has a consensus target price of $131.6429, indicating a potential upside of 6.84%. Mettler-Toledo International has a consensus target price of $868.0833, indicating a potential downside of 17.56%. Given PerkinElmer's stronger consensus rating and higher probable upside, analysts clearly believe PerkinElmer is more favorable than Mettler-Toledo International.

Profitability

This table compares PerkinElmer and Mettler-Toledo International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PerkinElmer12.74%21.57%9.61%
Mettler-Toledo International19.36%144.89%21.11%

Earnings & Valuation

This table compares PerkinElmer and Mettler-Toledo International's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PerkinElmer$2.88 billion4.79$227.56 million$4.1030.05
Mettler-Toledo International$3.01 billion8.17$561.11 million$22.7746.14

Mettler-Toledo International has higher revenue and earnings than PerkinElmer. PerkinElmer is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

PerkinElmer has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500.

Summary

Mettler-Toledo International beats PerkinElmer on 10 of the 14 factors compared between the two stocks.


Mettler-Toledo International Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Thermo Fisher Scientific logo
TMO
Thermo Fisher Scientific
2.3$449.69-0.6%$175.97 billion$25.54 billion36.86Analyst Report
Illumina logo
ILMN
Illumina
1.6$392.56-1.6%$58.19 billion$3.54 billion91.08Analyst Report
Agilent Technologies logo
A
Agilent Technologies
1.8$117.28-1.0%$35.39 billion$5.34 billion50.99
Bio-Rad Laboratories logo
BIO
Bio-Rad Laboratories
1.5$562.48-1.0%$16.95 billion$2.31 billion4.81
Waters logo
WAT
Waters
1.3$267.72-0.5%$16.57 billion$2.41 billion33.34Decrease in Short Interest
PerkinElmer logo
PKI
PerkinElmer
1.9$123.21-0.7%$13.89 billion$2.88 billion33.48
Bio-Techne logo
TECH
Bio-Techne
2.0$349.38-2.0%$13.82 billion$738.69 million55.90Analyst Upgrade
Charles River Laboratories International logo
CRL
Charles River Laboratories International
1.5$275.12-0.5%$13.63 billion$2.62 billion45.85
Bruker logo
BRKR
Bruker
1.9$59.65-0.4%$9.00 billion$2.07 billion58.48Decrease in Short Interest
Pacific Biosciences of California logo
PACB
Pacific Biosciences of California
1.6$27.92-4.8%$5.65 billion$90.89 million-99.71Decrease in Short Interest
Gap Up
Luminex logo
LMNX
Luminex
1.8$32.24-0.0%$1.50 billion$334.64 million82.67
Fluidigm logo
FLDM
Fluidigm
1.8$3.99-3.0%$306.39 million$117.24 million-5.96
Harvard Bioscience logo
HBIO
Harvard Bioscience
1.1$4.29-1.2%$165.26 million$116.18 million-23.83Upcoming Earnings
aTyr Pharma logo
LIFE
aTyr Pharma
1.5$4.41-4.3%$42.98 million$420,000.00-1.66Gap Down
This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.